- Simulations Plus and the University of Bath Awarded New FDA Grant (11/15/22)
- Simulations Plus and the University of Florida Awarded New FDA Contract to Support Development and Regulatory Assessment of Inhaled Products (11/2/22)
- Simulations Plus Enters New Collaboration to Enhance Machine Learning Models for Ionization Constants (pKa) (8/4/22)
- Simulations Plus Collaborates with Multinational Pharmaceutical Company to Provide Modeling & Simulation Support for COVID-19 Treatment (6/23/22)
- U.S. FDA Renews Annual DILIsym® Software Licenses for 2022 (5/5/22)
- Simulations Plus Successfully Delivers FDA-Funded Project (4/28/22)
- Simulations Plus Enters New Collaboration to Advance DDDPlus™ Software (4/21/22)
- Simulations Plus Receives $1.7 Million Grant for BIOLOGXsym™ Macromolecule Safety Software (3/29/22)
- Simulations Plus Partners with Large Pharmaceutical Company to Drive Advancements to the GastroPlus® Mechanistic Oral Absorption Model (1/20/22)
- Simulations Plus Enters New Collaboration with Leading Animal Health Company (1/13/22)